200670.KQ
Humedix Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 25,200.00
−2.14%Margins
Gross margin
43.7%
EBITDA margin
28.3%
EBIT margin
22.8%
Net margin
25.8%
FCF margin
14.5%
14.9%
Return on equity
13.7%
Return on assets
13.1%
Return on invested capital
0.53x
Asset turnover
KRW 38.9B
Cash from operations
KRW 3.5K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026